A Clinical Study of Ovarian Clear Cell Carcinoma

In: Korean Journal of Gynecologic Oncology and Colposcopy · 2002 · vol. 13(4) , pp. 305 · doi:10.3802/kjgoc.2002.13.4.305 · W2406802146
article OA: bronze CC0 ⤵ 1 in-corpus citation

Abstract

Objective : The aim of this study is to evaluate the clinical characteristics of clear cell carcinoma of the ovary. Methods : Between 1993 and 2001, 23 patients with clear cell carcinoma of ovary treated in the department of obstetrics and gynecology, Catholic University Medical College were identified and reviewed retrospectively for patient profiles, International Federation of Gynecologists and Obstetricians (FIGO) disease stage, mode of therapy, and length of survival. Results : Median age was 47 years (range 36-68 years). Tumors were 609%0 (14/23) stage I, 4.31% (1/23) stage II, 35.28% (8/23) stage III. All patients presented with a pelvic mass ranging in size from 5 cm to 27 cm. Of the patients with clear cell carcinoma, six (26.1%) had associate d endometriosis. All patients underwent cytoreductive surgery followed by postoperative chemotherapy. The median follow up for surviving patients is 48.15 months (range 0.9 to 95.4 months). The overall 3-year survival rates were 69.5%. The survival was 38.6 months. Conclusion : Clear cell carcinoma of the ovary is intriguing histologic type of epithelial cancer and demonstrates a clinical behavior distinctly different from that of other epithelial ovarian cancer. Predictors of survival for patients with clear cell carcinoma of the ovary needs to be further investigated by randomized large number study.
Full text 1,496 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Abstract

OBJECTIVE The aim of this study is to evaluate the clinical characteristics of clear cell carcinoma of the ovary.

Methods

Between 1993 and 2001, 23 patients with clear cell carcinoma of ovary treated in the department of obstetrics and gynecology, Catholic University Medical College were identified and reviewed retrospectively for patient profiles, International Federation of Gynecologists and Obstetricians (FIGO) disease stage, mode of therapy, and length of survival.

Results

Median age was 47 years (range 36-68 years). Tumors were 60.9% (14/23) stage I, 4.31% (1/23) stage II, 35.28% (8/23) stage III. All patients presented with a pelvic mass ranging in size from 5 cm to 27 cm. Of the patients with clear cell carcinoma, six (26.1%) had associated endometriosis. All patients underwent cytoreductive surgery followed by postoperative chemotherapy. The median follow up for surviving patients is 48.15 months (range 0.9 to 95.4 months). The overall 3-year survival rates were 69.5%. The survival was 38.6 months.

Conclusion

Clear cell carcinoma of the ovary is intriguing histologic type of epithelial cancer and demonstrates a clinical behavior distinctly different from that of other epithelial ovarian cancer. Predictors of survival for patients with clear cell carcinoma of the ovary needs to be further investigated by randomized large number study.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK